Unveiling of the Entire Cryo-EM Structure for Botulinum Toxin Complex

In a groundbreaking discovery, researchers at Stockholm University have visualized the entire large toxin complex of Botulinum neurotoxin serotype B1 for the first time. The findings, published in the scientific journal Science Advances in the paper titled, "Structure of the complete 14-subunit botulinum neurotoxin B complex reveals a unique anchoring through the narrow central pore of HA70," offer new opportunities to neutralize the toxin or harness its mechanisms for therapeutic use.

The research reveals the structure of the complete 14-subunit progenitor toxin complex (L-PTC) and its five subcomplexes. The L-PTC interacts with its associated components, providing insights into how the toxin is stabilized, delivered, and released. The study also sheds light on how the toxin interacts with the cell surface, a crucial step in its journey to its ultimate target, the connection between nerves and muscles.

One of the key findings is the role of the HA subcomplex, which presents a tripod architecture with flexible legs that may adapt to the rugged cell surface. Another significant discovery is the pH dependence of botulinum toxin release from the complex, which is unexpectedly influenced by the presence of HA70.

The Clostridium genus produces botulinum neurotoxins, the most potent biological toxins known. In nature, botulinum toxin does not act alone, but travels within a large, 14-part protein complex. This protein complex shields the toxin from the harsh environment in the gut and helps it cross from the gut into the blood.

Botulinum neurotoxins have medical uses, including treating chronic migraines, muscle spasms, severe sweating, and for cosmetic purposes. However, this research does not delve into the medical applications, classification, or nature of botulinum neurotoxins or the botulism disease.

According to the lead researcher, Stenmark, gaining insight into how this complex system works and what it looks like is very exciting. The new structure offers new opportunities to neutralize the toxin or harness its mechanisms for therapeutic use. The research paves the way for the development of more effective drugs.

The NTNH-nLoop adopts a unique fold that locks the M-PTC into a central pore formed by HA70, providing a detailed understanding of the assembly mechanism. This understanding could be crucial in the development of strategies to interfere with the toxin's function or delivery.

Botulism is caused by the blockage of neurotransmitter release from nerves due to ingestion of botulinum neurotoxins. Understanding the structure of the toxin complex could lead to the development of strategies to prevent or treat botulism effectively.

The research provides a comprehensive view of the botulinum toxin complex, offering valuable insights into its structure and function. These findings could pave the way for the development of new treatments and therapies, offering hope for those affected by botulism and the conditions treated with botulinum toxins.